ClinConnect ClinConnect Logo
Search / Trial NCT04647968

Primary vs Secondary Closure of Tracheo-cutaneous Fistulas

Launched by UNIVERSITÉ DE SHERBROOKE · Nov 23, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Tracheostomy Tracheostomy Closure Tracheocutaneous Fistula

ClinConnect Summary

This clinical trial is investigating two different methods for closing a tracheo-cutaneous fistula, which is an opening that can develop after a tracheostomy (a procedure where a tube is placed in the windpipe to help with breathing). The trial aims to compare "primary closure," where the opening is closed right away, and "secondary closure," where the opening is allowed to heal over time before being closed. By studying these methods, researchers hope to find out which technique leads to better outcomes for patients.

To participate in this trial, individuals must be between 65 and 74 years old, have a tracheostomy (either done through the skin or surgically), and be ready to have their tube removed and the fistula closed. It's important to note that those with certain conditions that would prevent immediate closure or who are unable to give consent cannot join the study. Participants can expect to receive care and monitoring as they undergo either of the closure methods, helping to contribute valuable information that could improve treatment for others in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being covered by the RAMQ
  • Having a tracheostomy either percutaneous or surgical
  • Being ready for canula removal and closure of the fistula
  • Exclusion Criteria:
  • Presenting a contraindication to primary tracheotomy closure (granuloma)
  • Unable to consent
  • Refusal to participate

About Université De Sherbrooke

The Université de Sherbrooke is a leading research institution in Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. With a focus on interdisciplinary collaboration, the university actively engages in clinical trials to explore new therapeutic interventions and improve patient care. Its research team comprises experienced professionals dedicated to ensuring the highest ethical standards and scientific rigor in clinical research. The Université de Sherbrooke strives to translate research findings into practical solutions that enhance health outcomes and contribute to the advancement of medical science.

Locations

Sherbrooke, Quebec, Canada

Patients applied

0 patients applied

Trial Officials

Simon Brisebois, MD, MSC

Principal Investigator

Université de Sherbrooke

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials